Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
Volume
17
DOI
10.1186/s12879-017-2517-3
Journal
BMC INFECTIOUS DISEASES
ISSN
1471-2334
Metadata
Show full item recordAuthors
Cunningham, EB; Hajarizadeh, B; Dalgard, O; Amin, J; Hellard, M; Foster, GR; Bruggmann, P; Conway, B; Backmund, M; Robaeys, GURI
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-017-2517-3http://qmro.qmul.ac.uk/xmlui/handle/123456789/34803
Collections
- Centre for Immunobiology [1098]